Ctxr analyst report
WebCitius Pharmaceuticals (CTXR) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Citius Pharmaceuticals reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.286%. WebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .
Ctxr analyst report
Did you know?
WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. WebApr 10, 2024 · Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. About the company. CTXR fundamental analysis. Snowflake Score. Valuation. …
WebApr 12, 2024 · Valuation is complex, but we're helping make it simple. Find out whether Citius Pharmaceuticals is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.. View the Free Analysis WebMar 1, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously approved ...
WebMay 13, 2024 · Your NASDAQ Biotech Idea CTXR Just Triggered Multiple Short-term Technicals As Bullish. Dawson James Securities Analyst Report. May 13th. SCF Members, As of 10:00AM EST, Barchart.com reported "BUY" opinions for several short-term technical indicators on CTXR including: 20 Day Moving Average; 20 - 50 Day MACD Oscillator; 20 … WebApr 13, 2024 · CTXR Stock Price Performance Analysis. Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 98.73%. However, over the last six months, the performance has been …
Web1 day ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ...
WebMar 31, 2024 · The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays ... songs that go with psalm 23WebCTXR 2M Long Term test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a … small galvanized metal trayWeb20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius … songs that go with the outsiders bookWebCitius Pharmaceuticals Inc. (CTXR) Analyst Forecast CTXR Price, Volume, Earnings, and Dividend Date Last Price $1.17 Previous Close $1.10 Change $0.07 Open $1.10 Volume … small galvanized tin lettersWebFeb 20, 2024 · An analysis of the Citius Pharmaceuticals Inc. (NASDAQ:CTXR) stock in terms of its daily trading volume indicates that the 3-month average is 826.91K. However, this figure increases on the past 10-day timeline to an average of 0.7 million. Current records show that the company has 146.15M in outstanding shares. songs that go togetherWebApr 3, 2024 · Live In Play®. CRANFORD, N.J. , April 3, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that the last patient has been enrolled in the Company's Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoids. CITI-002 would be the first ... songs that have 120 bpmWebThe Citius Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … songs that has good bass